QAIBio

QAIBio aims to reduce the over $400B annual losses due to drugs that fail in the clinical trial value chain. Q-Tool will focus on optimizing the number one reason why drugs fail: toxicity and safety. The Quantum-Enhanced Universal Redesign Algorithm (QUR) represents a significant advancement in drug discovery and repurposing by integrating multiple quantum-enhanced techniques to facilitate the redesign and repurposing of failed drug candidates. Q-Tool leverages quantum computing to explore extensive chemical spaces, optimize molecular structures, and predict drug-target interactions with unprecedented precision. The QUR methodology incorporates Quantum Multidimensional Encoding (QME), Dynamic Quantum Molecular Dynamics (DQMD), Fractional Quantum Spectroscopy (FQS), and Quantum-Classical Adaptive Resonance (QCAR) to address the critical challenges of drug discovery and repurposing.